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1. 
METHOD FORMONITORING THE 
STEREOSELECTIVITY AND RELATIVE 
RATE OF ORGANIC CHEMICAL 
REACTIONS 
This application claims benefit to provisional application 
60/681,157 filed May 16, 2005. 
This invention was made with government Support under 
CHE0317083 awarded by the National Science Foundation. 
The government has certain rights in the invention. 
FIELD OF THE INVENTION 
This invention relates to a method for the in situ monitoring 
of stereoselectivities and relative rates of reaction. 
BACKGROUND OF THE INVENTION 
Combinatorial methods have made an important impact on 
catalyst discovery in recent years. Notable examples include 
the discovery of catalysts for asymmetric acylation and Stet 
ter-type chemistry, Pd(0) and Cu(I)-mediated allylic alkyla 
tions, Ag-based carbene insertion, FeCl-mediated epoxida 
tion, and early transition metal-based additions to imines. 
These Successes have spurred interest in catalyst Screening. 
Thus, screens for active lead catalysts, based upon IR ther 
mography fluorescence and dye formation/bleaching have 
been reported. However, some methods for estimating rela 
tive rates, for example, involve the alteration of the substrate 
by the installation of a chromophore. In some cases, the 
Substrate is so significantly altered, that a positive result in the 
screen, does not translate into a positive result with the origi 
nal, unperturbed Substrate. 
Particularly valuable screens also provide information on 
enantioselectivity. Such screening methods include chiral GC 
and HPLC, CD and ORD and methods based upon installing 
MS or fluorescence tags or condensations with indicators. 
The most common methods for estimating enantioselec 
tivity are time-consuming and serial in nature. They involve 
chiral chromatography (usually HPLC or GC), and can be 
automated by the use of auto-injectors, but have the disad 
Vantages of (i) requiring reaction quenching and work-up and 
of (ii) offering little possibility for parallel screening. Other 
approaches to estimating enantiomeric excess require that the 
product be derivatized, in a separate kinetic resolution step, 
following work-up of the reaction. 
A reported in sits screen that provides information on both 
relative rate and productee employs an isotopically chiral'C 
NMR probe substrate. This allows obtaining information on 
both relative rate and enantioselectivity of the catalyst being 
screened, on the fly, without the need to draw aliquots. The 
disadvantage of that method is that it requires the Stereose 
lective synthesis of an expensive 13-C-enriched model sub 
strate. Furthermore, this approach placed the isotopically 
chiral, geminal dimethyl reporting group directly adjacent 
to the carbonyl reaction center, thereby creating steric hin 
drance. This limits the suitability of the model substrate to 
mimic more common Substrates for carbonyl addition reac 
tions that possess sterically less hindered carbonyl groups. 
As described in U.S. Pat. No. 6,974,665, the entire disclo 
sure of which is incorporated herein by reference, enzymes 
can be used to assist organic chemists, using an approach 
termed “in situ enzymatic screening (ISES). Enzymes are 
used to monitor relative rates in real time for allylic substitu 
tion catalysts run in parallel. ISES(InSitu Enzymatic Screen 
ing) is run in a bilayer, in this case, with a lower, aqueous 
enzymatic layer (containing ethanol dehydrogenase and alde 
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hyde dehydrogenase) reporting (via NADH production) on 
the turnover of anallylic ethylcarbonate substrate in an upper 
organic reaction layer. The first examples of asymmetric, 
Ni(0)-mediated allylic amination reactions were uncovered 
in the process. 
BRIEF SUMMARY OF THE INVENTION 
One embodiment of the present invention provides a 
method for monitoring the stereoselectivity of at least one 
organic chemical reaction and the relative rate of at least one 
organic chemical reaction, wherein the reaction produces a 
product that can exist as at least two stereoisomers, the pro 
cess comprising: 
providing a first reaction Zone containing (1) an organic 
phase comprising the reaction mixture for producing the 
product and (2) an aqueous phase adjacent to but Substantially 
immiscible with the organic phase, the aqueous phase con 
taining at least one first sensing agent that preferentially acts 
ona first stereoisomer in the product to produce a monitorable 
change, the product being diffusible into the aqueous layer 
(2). 
providing a second reaction Zone containing (A) an organic 
phase also comprising the reaction mixture for producing the 
product and (B) an aqueous phase adjacent to, but Substan 
tially immiscible with the organic phase, the aqueous phase 
containing at least one sensing agent that is different from the 
first sensing agent and that 
i also preferentially acts on the first stereoisomer in the 
product, but with a different stereoselectivity for the 
stereoisomers formed in the product than the first sens 
ing agent to produce a monitorable change, 
ii acts at equal rates on both formed Stereoisomers of the 
product to produce a monitorable change or, 
iii preferentially acts on a second stereoisomer in the 
product to produce a monitorable change, 
the product being diffusible into the aqueous layer (B), 
conducting the reactions in the organic phases (1) and (A) 
to produce the products, 
allowing the products to diffuse into the aqueous phases (2) 
and (B) and react with the first and second sensing agents, 
monitoring the changes caused by the reactions with the 
first and second sensing agents and 
determining from the changes, the relative rate and stereo 
selectivity of the organic chemical reaction in the organic 
phases (1) and (2). 
Another embodiment of the invention relates to a kit 
adapted for efficiently carrying out the method of the inven 
tion. 
A further embodiment of the invention concerns a novel 
method for identifying a catalyst for an organic chemical 
reaction that efficiently forms a product that can exist as at 
least two stereoisomers and that is also stereoselective for at 
least one of the Stereoisomers comprising: 
providing a first reaction Zone containing (1) an organic 
phase comprising the reaction mixture for producing the 
product, the mixture containing a candidate catalyst for the 
reaction and (2) an aqueous phase adjacent to, but Substan 
tially immiscible with the organic phase, the aqueous phase 
containing at least one first sensing agent that preferentially 
acts on a first stereoisomer in the product to produce a moni 
torable change, the product being diffusible into the aqueous 
layer (2). 
providing a second reaction Zone containing (A) an organic 
phase also comprising the reaction mixture for producing the 
product and (B) an aqueous phase adjacent to, but Substan 
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tially immiscible with the organic phase, the aqueous phase 
containing at least one sensing agent that is different from the 
first sensing agent and that 
i also preferentially acts on the first stereoisomer in the 
product, but with a different stereoselectivity for the 
stereoisomers formed in the product than the first sens 
ing agent to produce a monitorable change or 
ii acts at equal rates on both formed Stereoisomers of the 
product to produce a monitorable change or 
iii preferentially acts on a second stereoisomer in the 
product to produce a monitorable change, 
conducting the reactions in the organic phases (1) and (A) 
to produce the products, 
allowing the products to diffuse into the aqueous phases (2) 
and (B) and react with the first and second sensing agents, 
monitoring the changes caused by the reactions with the 
first and second sensing agents and 
determining from the changes the relative rate of reaction 
and stereoselectivity of the catalyst. 
An additional embodiment of the invention relates to a 
method for preparing a catalyst for an organic chemical reac 
tion that produces a product that can exist as at least two 
Stereoisomers and that is also stereoselective for at least one 
of the stereoisomers comprising preparing a candidate cata 
lyst for said reaction and: 
providing a first reaction Zone containing (1) an organic 
phase comprising the reaction mixture for producing said 
product, said mixture containing a candidate catalyst for said 
reaction and (2) an aqueous phase adjacent to, but Substan 
tially immiscible with said organic phase, said aqueous phase 
containing at least one first sensing agent that preferentially 
acts on a first Stereoisomer in said product to produce a 
monitorable change, said product being diffusible into said 
aqueous layer (2). 
providing a second reaction Zone containing (A) an organic 
phase also comprising the reaction mixture for producing said 
product and (B) an aqueous phase adjacent to, but Substan 
tially immiscible with said organic phase, said aqueous phase 
containing at least one sensing agent that is different from 
said first sensing agent and that 
i also preferentially acts on the first stereoisomer in the 
product, but with a different stereoselectivity for the 
stereoisomers formed in the product than the first sens 
ing agent to produce a monitorable change or 
ii acts at equal rates on both formed Stereoisomers of the 
product to produce a monitorable change or 
iii preferentially acts on a second stereoisomer in the 
product to produce a monitorable change, 
said product being diffusible into said aqueous layer (B), 
conducting said reactions in said organic phases (1) and 
(A) to produce said products, 
allowing said products to diffuse into said aqueous phases 
(2) and (B) and react with said first and second sensing agents, 
monitoring the changes caused by said reactions with said 
first and second sensing agents and 
determining from said changes the relative rate and stereo 
selectivity of said catalyst. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows a comparison of predicted and observed ee's 
for the HKR oft-propylene oxide. 
FIG. 2 shows a comparison of predicted and observed 
relative rates (normalized to 4b) for Co(III)-salen mediated 
HHR of propylene oxide. 
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FIG.3 shows Michaelis-Menten Kinetic Analysis: Km and 
Vmax Determinations-HLADH. 
FIG. 4 shows Michaelis-Menten Kinetic Analysis: Km and 
Vmax Determinations-TBADH. 
FIG. 5 shows a comparison of predicted and observed ee's 
for the HKR oft-propylene oxide. 
FIG. 6 shows a comparison of predicted and observed ee's 
for the HKR of hexane oxide. 
FIGS. 7-7C show representative Co(III)-salen catalysts 
utilized in the examples below (salens and the Co catalysts 
prepared therefrom are numbered identically throughout the 
specification) 
FIG. 8 shows a plot of Dehydrogenase Enantiopreferences 
vs. 1.2-Propanediol Concentration for HLADH. 
FIG.9 shows a plot of Dehydrogenase Enantiopreferences 
vs. 1.2-Propanediol Concentration for TBADH. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention is predicated on the discovery that 
information on both the relative rates and stereoselectivities 
for an array of reactions can be provided in situ by conducting 
the reactions in parallel and observing the effects of the prod 
ucts produced thereby whenacted upon by different reporting 
agents, typically enzymes. The method of the invention dif 
fers significantly from that disclosed in U.S. Pat. No. 6,974, 
665. Specifically, (i) the reporting enzymes are used to 
observe the reaction product directly (for example a chiral 
1,2-diol), rather than a byproduct of catalyst turnover (for 
example EtOH). This allows use of the chirality in the report 
ing enzyme (chiral sensor). In addition (ii), two reporting 
enzymes are employed, in parallel vessels, to obtain informa 
tion on Stereoselectivity, as well as relative rates. 
The invention permits, e.g., the screening of an array of 
potential catalysts for reactions of interest, in parallel, and in 
situ. For example, two enzymes with differing stereoselectiv 
ity for the reaction product are employed. Each enzyme pro 
vides, e.g., a spectroscopic signal (e.g. NADH or NADPH 
formation) that can be detected by either UV/visible absorp 
tion spectroscopy or fluorescence spectroscopy. This spectro 
scopic signal can be followed in real time, while the reaction 
is taking place. 
The method of the invention utilizes techniques similar to 
those disclosed in U.S. Pat. No. 6,974,665. The method of the 
invention is utilized to distinguish the situation in which 
catalyst A has the same rate as catalyst B, but greater R:S 
selectivity, from the situation in which catalysts A and B 
display similar stereoselectivities, but catalyst A possesses a 
greater rate. 
The method does not require alteration of either the reac 
tant or the product, by installation of a chromophore or mass 
tag, for example. It has the further advantage of providing 
information in real time, without the need to draw aliquots, 
quench the reaction or perform a work-up. 
The invention requires that the reaction to be screened 
yield a product that reacts with the reporting (sensing) agent, 
e.g., an enzyme. Potential “reporting enzymes' are screened 
for both their substrate specificity and stereoselectivity. All 
that is required is that one have two different reporting 
enzymes that show different stereopreferences in their reac 
tions with the Stereoisomeric organic reaction product of 
interest. Reporting enzymes can be used for a variety of 
reactions. 
The method of the invention allows reliable predictions 
that can lead to the discovery of a number of interesting 
asymmetric catalysts. For example, the method has been used 
to screen an array of new chiral Co(III)-salen catalysts for 
US 7,767,388 B2 
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their ability to catalyze the hydrolytic kinetic resolution 
(HKR) of racemic, propylene oxide and hexene oxide. 
The method may be utilized in the form of a screening kit. 
The kit could contain, for example, separately packaged reac 
tion vessels (e.g., cuvettes or microtitre plates), the organic 
and aqueous liquid compositions, catalysts, buffers, and 
enzymes. These compositions could be packaged with or 
without organic and aqueous solvents. The kit could be pro 
vided with or without catalysts. In other words, for a screen 
ing kit without catalysts, the practitioner would supply his/her 
own catalyst candidates or catalyst candidate library to be 
screened. The kit could be provided with our without a test 
substrate. In the latter case, the practitioner would provide 
his/her own test substrate for the reaction of interest. 
Typically, in accordance with the method of the invention, 
two reaction vessels or two reaction wells containing an 
organic layer and an aqueous layer are placed in parallel. Each 
vessel contains the same organic layer and different aqueous 
reporting layers. 
To demonstrate proof of principle for the method of the 
invention, the hydrolytic kinetic resolution (HKR) of (+)- 
propylene oxide to 1,2-propane diol was chosen, a reaction 
known to be catalyzed efficiently by chiral Co(III)-salencom 
plexes. See Scheme 1. To provide an information-rich data set 
requires that the two reporting enzymes display different, 
ideally opposite stereoisomeric preferences. Preliminary 
screening revealed that alcohol dehydrogenase from horse 
liver (HLADH) and from Thermoaniaerobium brockii 
(TBADH) fulfill this criterion. The former enzyme prefers 
(S)-1,2-propanediol, whereas the latter favors the (R)-anti 
pode. A focused 7x7"salen’ array was designed (Table S3) so 
as to explore the interplay of novel chiral diamine scaffolds 
(from terpenoid, amino acid, and carbohydrate skeletons) 
with sterically and electronically diverse “salicylaldehydes, 
from which the Co(III)-salen catalysts were prepared. 
TBADH-cuvet 
aq. reporting layer 1 
common organic layer 
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In the experiment, each Co(III)-salen catalyst (at 0.25 
mol %) is placed in a lower organic layer (CHCl) and 
expoxide, 300 uL total volume) in each of two parallel 
cuvettes. Aqueous reporting layers containing TBADH/ 
NADP+ (cuvette 1) and HLADH/NAD+ (cuvette 2), respec 
tively, are then added. The increase in absorbance at 340 nm 
can be followed for several such sets in parallel by UV-vis 
spectrophotometry. The kinetic data are then used to make the 
double-cuvette ISES predictions. A comparison of the pre 
dicted and measured ee's is presented in FIG. 1. Of 49 new 
salens targeted, 42 were obtained, and 25 gave active Co(III)- 
catalysts. Above a 65% ee threshold in either direction, ISES 
found 9 of 11 true hits (18% false negatives) and succeeded in 
9 of its 12 predictions (25% false positives). Note that the 
measured ee's are for the HKR under the neat conditions 
typically used in the conventional Jacobsen method whereas 
the predicted ee's are for the bilayer used in double-cuvette 
ISES. FIG. 2 compares the relative rates of reaction predicted 
by ISES with those observed in a bilayer by "H NMR. 
Observed relative rates agree with ISES predictions to within 
25% in 9 of 10 cases measured, with the Co(III) salen catalyst 
5d displaying slightly greater variance. 
Interesting “combinatorial hits” include the finding that 
2-hydroxy-1-naphthaldehyde (c) yields catalysts with very 
low activity, whereas 1-hydroxy-2-naphthaldehyde (d) is the 
best partner for beta-pinene-derived diamine 1. Furthermore, 
a remarkable inversion of stereoselectivity is observed for 
salens emanating from the new B-D-fructopyranose-based 
diamine 7, upon going from the 3,5-di-tert-butylsalicylalde 
hyde partner (a) to the sterically less encumbered 3,5-diiodo 
congener (e). 
The following will be understood by those skilled in theart. 
Although the invention is illustrated with reference to the 
hydrolysis of epoxides, the method of the invention is appli 
cable for any organic chemical reaction that results in the 
H3 
... reporting layer 2 
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production of stereoisomers and particularly for Such reac 
tions that employ catalysts. In those methods wherein an 
alcohol is produced, the alcohol product may comprise a diol 
Such as the 1,2-propane- and 1.2-hexane-diols exemplified 
below or a halohydrin, a 3-azido alcohol, a 3-cyanoalcohol, a 
B-alkoxy alcohol, a B-aryloxy alcohol, a B-thioalkyl alcohol, 
B-amino alcohol, the product of an aldol-type condensation, 
wherein a carbon acid having a proton alpha to one or more 
electron-withdrawing groups (e.g., nitro group, carbonyl 
group (aldehyde, ketone, ester, amide), cyano group, Sulfonyl 
group, Sulfinyl group, Sulfoxide, phosphonate ester, isonitrile 
group, imine functionality) is condensed with an aldehyde 
and is deprotonated in the course of the condensation, the 
product of a Morita-Baylis-Hillman reaction, the product of a 
carbonyl reduction reaction or a cyanohydrin. The product 
may also comprise an amine wherein the sensing agents are 
amine dehydrogenase or amine oxidase enzymes that oxidize 
the product. Where the product is an aldehyde or hemiacetal 
the sensing agents in aqueous phases (2) and (B) may be 
aldehyde or alcoholdehydrogenase enzymes that oxidize said 
product. 
Moreover, any Suitable reaction medium, i.e., solvent and 
reaction adjuvants as well as aqueous medium may also be 
employed in the practice of the invention. Although the inven 
tion is illustrated employing enzymes as sensing agents, any 
Suitable Such agent that preferentially reacts with a specific 
Stereoisomer in the reaction product to produce a monitorable 
change in the aqueous medium may be utilized. Suitable 
enzymes include alcohol, amine or aldehyde oxidases or 
dehydrogenases, it being understood that one may couple the 
oxidase reaction with the (Horseradish) Peroxidase (HRP) 
reaction, wherein the hydrogen peroxide byproduct from the 
oxidase reaction leads to the oxidation of a dye co-substrate 
for the peroxidase enzyme, producing an observable signal. 
The monitorable change in the aqueous medium may also 
comprise any effect that is measurable by Suitable and appro 
priate monitoring techniques. In addition, the method of the 
invention is applicable for the evaluation of suitable known 
candidate catalysts as well as for the preparation of novel 
catalysts for reactions that produce mixtures of stereoiso 
mers. By the term, “relative rate' of organic chemical reaction 
is meant the relative rate of the reaction with reference to a 
'standard’ reaction, i.e., another reaction under investigation 
or a reaction known in the art. 
All reactions were conducted under argon atmosphere 
using flame or oven-dried glassware, unless otherwise indi 
cated. Methylene chloride was distilled from CaFI. Toluene, 
THF, and EtO were distilled from sodium benzophenone 
ketyl. Methanol was distilled from Mg, and ethanol from 
nadiethyl phthalate. Alcohol dehydrogenase from equine 
liver (HLADH, EC 1.1.1.1), alcohol dehydrogenase from 
Thermoanaerobium brockii (TBADH, EC 1.1.1.2), B-NAD+ 
(sodium salt), B-NADP+ (sodium salt), 3.5-Di-tert-butylsali 
cylaldehyde (a), 3-tert-butylsalicylaldehyde (b), 2-hydroxy 
1-naphthaldehyde (c), cobalt(II)-acetate tetrahydrate, 1-hy 
droxy-2-naphthaldehyde (d), 3,5-diiodosalicylaldehyde (e), 
4-benzyloxysalicylaldehyde (f) and 8-hydroxy-1,1,7,7-tet 
ramethylulolidinyl-9-carboxaldehyde (g) were purchased. 
Flash chromatography was performed using Merck silica 
gel 60 (230-400 mesh). 1H NMR spectra were recorded on 
Bruker-DRX-Avance-400 MHz, 500 MHZ and 600 MHz 
instruments with chemical shifts reported relative to residual 
CHC (7.25ppm) and CHCl (5.2 ppm). Proton-decoupled 
'C NMR spectra were acquired on Bruker-DRX-Avance 
400 MHz, 500 MHZ and 600 MHZ instruments with chemical 
shifts reported relative to CHCl (77.0 ppm). Optical rotation 
(a)589 nm was measured at 19°C. in an Autopol polarimeter. 
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IR spectra were obtained using a Nicolet Avatar 360 FTIR 
spectrometer. Mass spectra were acquired at the Nebraska 
Center for Mass Spectrometry (University of Nebraska-Lin 
coln). Enzyme assays and ISES were done in a Shimadzu 
UV-2101 PC spectrophotometer equipped with a CPS-260 six 
cell positioner and thermoelectric temperature control (set at 
25° C. for all experiments reported), or a Shimadzu 2401 
spectrophotometer, equipped with a 12-cell changer and 
water-jacketed cell holder for temperature control. Enantio 
meric excesses were determined using a Chiralcel OD (0.46 
mmx25 cm) chiral column. 
General Procedure A: Synthesis of Chiral Salen Ligands 
(illustrated for 2a). SeeTable S3 below. 
An oven-dried RB flask was charged with (1S)-phenyl-1, 
2-ethylenediamine (250 mg, 1.83 mmol) and 3,5-di-tert-bu 
tylsalicylaldehyde (861 mg, 3.67 mmol) and freshly distilled 
ethanol (2 mL). The reaction mixture was stirred at 45° C. for 
1 d whereupon, in most cases, the salen product crystallized 
out. The reaction temperature and time varied, as indicated in 
the individual procedures. In the case of 2a, the product could 
be obtained in pure form (823 mg, 79%) by simple trituration 
with cold ethanol. If further purification was required, recrys 
tallization or column chromatography was used. 
N,N'-Bis(3',5'-di-tert-butylsalicylidene 1R-(1C.2C. 
5O)-2-amino-7,7-dimethyl-2-bicyclo[3.3.1 heptane 
ethanamine (1a) 
Diamine 1 was prepared from commercially available 
(1S)-(-)-3-pinene as described. General Procedure A was 
followed. Diamine 1 (43.3 mg, 0.32 mmol) and 3,5-di-tert 
butylsalicylaldehyde (150 mg, 0.64 mmol) were heated at 
40-50° C. for 5 h, filtered and triturated (cold EtOH), to 
produce clean la (140 mg, 92%): C.19 D+14.2 (c 3.54. 
CHCl); 1H NMR (400 MHz, CDC1) & 1.23 (d. J=10 Hz, 
1H), 1.23 (s.3H), 1.26 (s.9H), 1.26 (s.9H), 1.36 (s.3H), 1.43 
(s, 9H), 1.43 (s.9H), 1.92-1.97 (m,3H), 2.03 (app t, J=11, 10 
HZ, 1H), 2.17-2.26 (m, 2H), 2.28-2.32 (m, 1H), 2.42 (t, J–5.5 
HZ, 1H), 3.70 (d. J=8 Hz, 1H), 3.91 (d. J=8 Hz, 1H), 6.98 (d. 
J=2 Hz, 1H), 7.04 (d, J-2 Hz, 1H), 7.32 (d, J-2 Hz, 1H), 7.33 
(d. J–2 Hz, 1H), 8.25 (s, 1H), 8.264 (s, 1H), 13.62 (brs, 1H), 
14.36 (brs, 1H); 13C NMR (100 MHz, CDC1) & 23.9, 25.6, 
25.8, 28.2, 28.6, 29.5, 31.47, 31.49, 34.1, 35.0, 35.1, 38.5, 
40.0, 48.6, 67.2, 68.8, 117.8, 117.8, 126.0, 126.4, 126.6, 
126.9, 136.5, 136.5, 139.6, 139.9, 158.1, 158.6, 162.69, 
167.71; HRMS (FAB, 3-NOBA) calcd for CHNO. 
(M+H)+ 601.4733, obsd. 601.47 10. 
N,N'-Bis(3'-tert-butylsalicylidene)-1R-(1C.2O,5C.)- 
2-amino-7,7-dimethyl-2-bicyclo[3.3.1 heptaneetha 
namine (1b) 
General Procedure A was followed. Diamine 1 (101 mg, 
0.60 mmol) and 3-tertbutyl-2-hydroxybenzaldehyde (214 
mg, 1.20 mmol), and chromatographic purification (5% EtN 
hexenes), produced compound 1b (180 mg, 61%): C.19 D 
+2.66 (c 4.65, CH,Cl); 1H NMR (400 MHz, CDC1) & 1.05 
(d. J=10.8 Hz, 1H), 1.23 (s. 21H), 1.35 (s.3H) 1.89-2.06 (m, 
3H), 2.13-2.31 (m,3H), 2.41 (appt, J–5.6, 5 Hz, 1H), 3.76 (d. 
J=12 Hz, 1H), 3.86 (d. J=12 Hz, 1H), 6.84 (t, J=8 Hz, 2H), 
7.10 (dd, J=9.0, 2 Hz, 2H), 7.29 (dt, J=9.2 Hz, 2H), 8.13 (s, 
1H),8.17 (s, 1H), 13.12 (s, 1H), 13.63 (s, 1H); 13C NMR (100 
MHz, CD.C.) & 23.8, 25.7, 28.2, 28.5, 31.39, 31.41, 33.9, 
38.4, 40.0, 46.3, 48.3, 67.6, 68.9, 116.4, 166.5, 117.8, 117.9, 
127.9, 129.4, 129.7, 140.9, 1412, 158.7, 159.2, 1618, 167.1; 
HRMS (FAB, 3-NOBA) calcd for C.H.O.N. (M+H)+ 
489.3481, obsd 489.3492. 
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B. Standardization of HLADH: The assay cuvette con 
tained the following components: 7.2 mM (33 uL of 220 mM 
stock) of NAD+, 2 uI of HLADH stock solution, 865uI of 50 
mM sodium pyrophosphate buffer, pH 8.8, and 200 mM (100 
uL of 2M stock) of (R)-1,2-propanediol. The reaction was 
initiated by the addition of the (R)-1,2-propanediol, which 
typically gave a rate of 0.25+0.01 Abs/min at 25°C., 340 nm. 
This was indicative of 0.020 U of HLADH peruLofthe stock 
Solution. 
C. Standardization of TBADH: The assay cuvette con 
tained the following components: 2.2 mM (10 uI, 220 mM 
stock) NADP+, 2I of TBADH stock solution, 888 uL of 50 
mM sodium pyrophosphate buffer, pH 8.8, and 200 mM (100 
uL of 2M stock) of (R)-1,2-propanediol. The reaction was 
initiated by the addition of the (R)-1,2-propanediol, which 
typically gave a rate of 0.275+0.001 Abs/min at 25°C., 340 
nm. This was indicative of 0.022 U of TBADH per uL of the 
stock solution. 
IV. Dehydrogenase Enantioselectivities 
A. Relative Velocity (Vrel) Determinations 
1. HLADH: The enantioselectivity of TBADH was esti 
mated from the ratios of the initial velocities of (R)- vs. 
(S)-1,2-propanediol at fixed concentrations between 4.0 and 
100 mM at 25°C. Each velocity measurement was made in 
duplicate. The assay cuvette contained the following: 7.2 mM 
NAD+ (33 uL from a 220 mM stock), 0.049 U of HLADH, 
and various concentrations of either the (R)- or (S)-enanti 
omer of 1,2-propanediol. In all cases, the final Volume was 
adjusted to 1 mL using 50 mM sodium pyrophosphate buffer, 
pH 8.8. The concentration of NAD+ was fixed at saturating 
levels here, as reported Kim values for NAD+ with HLADH 
range from 38 to 629 uM. 
2. TBADH: The enantioselectivity of TBADH was esti 
mated from the ratios of the initial velocities of (R)- vs. 
(S)-1,2-propanediol at fixed concentrations between 3.0 and 
80 mM at 25°C. Each velocity measurement was performed 
in triplicate. The assay cuvette contained the following: 2.2 
mM NADP+ (10 uL from a 220 mM stock), 0.113 U of 
TBADH, and various concentrations of either (R) or (S)- 
enantiomer of 1,2-propanediol. In all cases, the final Volume 
was adjusted to 1 mL using 50 mM sodium pyrophosphate 
buffer, pH 8.8. The concentration of NADP+ was fixed at 
saturating levels here, as reported Kim value for NADP+ with 
TBADH is 13 uM.9 
The data are collected in FIGS. 8 and 9 and in Table S2 
below. One sees that TBADH displayed a significant prefer 
ence for the (R)-1,2-propanediol, and that HLADH favored 
the (S)-antipode, though not to the same degree. For each 
dehydrogenase, the relative velocities are relatively flat as a 
function of diol concentration FIGS. 8 and 9. In each case, 
there is a slight increase in enantioselectivity as one goes to 
lower concentration, indicating that each enzyme displays the 
same enantiomeric preference in the binding step (i.e. lower 
Km) as in the catalytic step (higher kcat or Vmax). 
TABLE S2 
Tabulated Dehydrogenase Enantioselectivities vs. Diol Concentration 
1.2-Propanediol 
Conc. (mM) 
4 8 12 16 2O 30 40 50 1OO 
Vsive of 4.O 3.6 2.8 2.4 2.7 2.8 3.0 2.7 2.6 
HLADH 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
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TABLE S2-continued 
Tabulated Dehydrogenase Enantioselectivities vs. Diol Concentration 
1.2-Propanediol 
Conc. (mM) 
3 6 10 2O 30 40 50 60 8O 
VR vs of 10.8 8.9 9.9 10.6 9.1 8.4 9.0 9.1 8.6 
TBADH 
The flatness of each graph Suggests that Kim's for the two 
enantiomers are likely not very different with either dehydro 
genase. Indeed, this was confirmed by the determination of 
Kim’s for each antipode of 1,2-propanediol for each enzyme. 
For each antipodal diol, the same data as were used to Survey 
dehydrogenase enantioselectivity, as a function of diol con 
centration, were plotted in Michaelis-Menten fashion, as v0 
vs. S (FIGS. 3 and 4). For each dehydrogenase, the data 
curve for (R)-1,2-propanediol is shown by --, and those for 
the (S)-enantiomer by -O-. In all four cases, the data were 
processed by linear, least squares fitting to a hyperbolic func 
tion. The resulting curve fits and best fit hyperbolic equations 
are presented above. For HLADH, the following steady state 
kinetic parameters were obtained: 
(R)-1,2-propanediol-Km=25+2 mM and 
Vmax=355+9 mAbs min-1 vs. 
(S)-1,2-propanediol-Km=16+1 mM and 
Vmax=819-20 mAbs min-1. 
Translating these data into the ratio of catalytic efficiencies 
for the two enantiomers, one obtains (Vmax/Km)S+(Vmax/ 
Km)R=3.6. This is consistent with the trends seen in enan 
tioselectivity vs. concentration, as the HLADHenantioselec 
tivity tends toward ~4:1 (S:R) as one tends toward low diol 
concentrations (see Table S2 and FIGS. 8 and 9). 
For TBADH, the following kinetic constants were 
obtained: 
(R)-1,2-propanediol-Km=17+2 mM and 
Vmax=487-18 mAbs min-1 vs. 
(S)-1,2-propanediol-Km=23+4 mM and Vmax=60+4 
mAbs min-1. 
Here, the ratio of catalytic efficiencies for the two enantio 
meric diols is dominated by the Vmax terms and yields 
(Vmax/Km)R--(Vmax/Km)S=11. Again, one sees nice 
agreement with trends observed in the enantioselectivity vs. 
concentration data, where the enantioselectivity tends toward 
~11:1 (R:S) as one tends toward low diol concentrations (see 
Table S2 and FIGS. 8 and 9). 
V. Double Cuvette-ISES (In Situ Enzymatic Screening) Pro 
cedure 
A general procedure for double cuvette-ISES to estimate 
both enantioselectivities and relative rates for an array of 
catalysts being screened in parallel is presented below. The 
hydrolytic kinetic resolution (HKR) of (+) propylene oxide 
was chosen as model reaction. An inverted bilayer with 
CHC as the organic solvent was chosen for this study, 
though initial trials indicate that other solvents both more 
dense (alternative lower organic layers), and less dense (up 
per organic layer) than the aqueous reporting layer, will also 
work. 
Typically, quartz cuvettes with one cm light paths and with 
nominal one mL. Volumes were used. For each catalyst, a two 
cuvette Screen was performed, with cuvette A containing 
HLADH, as (S)-propanediol-selective reporting enzyme, and 
cuvette B containing TBADH, as a (R)-propanediol-selective 
reporting enzyme. For each cuvette, the final volume was 800 
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uL (300 uL of organic layer; 500 uL of aqueous layer). This 
experimental set-up sent the spectrophotometer light beam 
cleanly through the aqueous reporting layer, as control 
experiments established that the beam passes through 1 mL 
cuvettes between the 600 and 700 uL volume levels. 
A. Organic Layer Composition: 
Both cuvettes A and B had the following composition: 150 
uL (2.15 mmol) of (+)-propylene oxide (7.2 M in organic 
28 
VI. Estimation of Enantioselectivity for Catalysts Screened 
Previously, in monitoring transition metal-mediated allylic 
substitution chemistry, ISES conditions were found in which 
a reliable signal could be obtained in 10-20 min. For fast 
catalysts, it was found that a 15 minute time window sufficed 
to provide meaningful ISES rates in the two reporting 
cuvettes, allowing for catalyst characterization. This time 
window was employed for all catalysts displaying rates Sur 
passing 50 mAbs/min (fastest rate of the two reporting 
cuvettes). For catalysts exhibiting ISES rates s50 mAbs/min layer), 150 uL of CHCl and 0.25 mol%. Co(III)-salen cata- 10 lvst. The total organic laver volume was maintained as 300LL over the first 15 minutes, a longer observation window WaS 
y 9. y l chosen (35 minute total), so as to obtain a better signal. in all catalyst Screens. Generally, catalysts displaying ISES rates of less than 20 
B. Aqueous Layer Composition: mAbs/min over 35 minutes were not pursued further. 
The following expression was used to estimate catalyst (i) Cuvette A: 0.35 UHLADH (17.6 uL from a stock is enantioselectivity: 
solution (0.02 U/uL)), 7.2 mM B-NAD+(16.5 uL from a 220 
mM stock) and 465.8 uL of 50 mM sodium pyrophosphate (i. VE2 - ve 
buffer, pH 8.8. The final pH was 8.6. Catalyst Enantioselectivity= IRIA Selel 
(ii) Cuvette B: 0.35 UTBADH (15.8 uL from a stock S Sele2 (VE - VE2) 
solution (0.022 U/LL)) of 2.2 mM B-NADP+ (5 uL from a 20 
220 mM stock) and 479.5 LL of 50 mM sodium pyrophos- where the velocities in each of the reporting enzyme 
phate buffer, pH 8.8. The final pH was 8.6. The total volume cuvettes, VE1 and VE2, respectively, were taken as the 
of the aqueous layer was maintained as 500 uL in both AAbs/time values (typically the average of two runs) seen 
cuvettes in all ISES experiments. over the time window. 
C. Step by Step Protocol: A catalyst stock solution (22 25 The parameters, Selei and Selle Were taken as the 
umol of catalyst in 620 uL CHCl) was made up in a 1.5 ml observed reporting enzyme enantioselectivies (a 40 mM diol 
microcentrifuge tube, and stored on ice, along with a stock of concentrations (see Table S2): 
(t)-propylene oxide, in a separate tube. The organic layers SelHLADH=E1=v RivS (HLADH)(a)40 mM=0.34 
were prepared by briefly vortexing 150 uL (5.4 umol. 0.25 
mol %) of the catalyst stock in CHCl with 150 uL (2.15 30 SelTBADH=E2=vRivS (TBADH)(a)40 mM=8.4. 
mmol) of (t)-propylene oxide in iced microcentrifuge tubes. This approximation was chosen, based upon the following 
These were loaded into 1 mL quartz cuvettes using precooled considerations. Control experiments established that under (refrigerator), disposable 1 mL Syringes. The aqueous layers ISES conditions, 1,2-propanediol concentrations in the aque 
were then layered on top of the organic layers, by Syringe, ous layer were in the range of 2-100 mM, for active catalysts 
down the walls of the cuvette. A reversed loading method was 35 over the observed time window. 
adapted for the catalysts made using 1-hydroxy-2-naphthal- The enantiomeric excesses predicted from the double 
dehyde (aldehyde 'd) in order to get a clear bilayer. In par- cuvette-ISES data, using this equation and empirical selec 
ticular, it was found practical for these catalysts to load the tivity factors, for Co(III)-salen complexes in the library, 
aqueous layer first. Then, the organic layer was syringed indexed by Salen, are displayed in the upper number in each 
beneath the aqueous layer. Catalyst screens were routinely 40 box in Table S3 below. For comparison purposes, ee's deter 
run in duplicate (i.e. two runs of cuvette A and two of cuvette mined for the same catalysts under standard Jacobsen con 
B per screen), with ISES rates taken as the average of the two ditions (neat propylene oxide, no co-solvent, 0.55 equiv. 
AO.D.340/time values obtained, for the appropriate time win- H2O, 3 h reaction time) are displayed below each prediction 
dow (vide infra). in the lower number. 
TABLE S3 
Measured vs. Predicted Enantiomeric Excesses for the Catalyst Library 
CHO 
-- 
Bu 
8. 
--56 NH 2 --72 
Me 
NH2 
CHO 
Bu C 
b 
d 
+68 S -75 
-75 +81 
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TABLE S3-continued 
Measured vs. Predicted Enantiomeric Excesses for the Catalyst Library 
CHO CHO CHO 
I OH BO OH 
f 
I N 
e 
9. 
Me NH2 . S S 
Me 
NH2 
1 
NH2 +4 S -41" 
-41 -71 
NH2 
2 
NH2 S S s 
NH2 
3 
+43" --57 S 
+14 +51 
NH2 
NH2 
4 
NH2 
O 
Me 
US 7,767,388 B2 
TABLE S3-continued 
Measured vs. Predicted Enantiomeric Excesses for the Catalyst Library 
- Me +87 (+85)* S s 
O +81 (+83)* 
-O NH2 
O 
x-d NH2 Me 
Me 
7 
Each box provides data for the Co(III)-salen acetate 
derived from the indicated salen. Presented are the 96 ee of the 
1.2-propanediol product, as predicted by double-cuvette 
ISES (upper number), and as observed by chiral HPLC (lower 
number). The cuvette experiments are run in a bilayer of pH 
8.6 buffer over 7.2M epoxide in CHCl, containing 0.25 mol 
% catalyst, for 15-35 min. Inherent catalyst ee's are judged 
by running the HKR in neat propylene oxide, containing 0.55 
equiv. of H2O, also at 0.25 mol % catalyst. These catalysts 
gave ISES signals <20 mAbs min-1 over 35 min. This 
catalyst was tested at 0.05 mol %, as it was especially fast. 
"The catalysts derived from 2g and 4e displayed ISES rates of 
14.9 and 18.1 mAbs min-1, respectively, in the HLADH 
cuvette, over 35 min. Difficulty was encountered in synthe 
sizing appreciable quantities of these salens. The 3,5-dini 
trobenzoate counterion was employed for these Co (III) cata 
lysts. 
VII. Estimation of Relative Rates for Catalysts Screened 
In order to rank catalysts in terms of relative rate, ISES 
rates, VE1 and VE2, over the 15 minute time window, were 
imported into the expression for total diolcatalyst A/total 
diolcatalyst B shown below. Note that the selectivity factors 
used here, SelE1 and SelB2, are the same as those used in the 
expression for enantioselectivity just discussed (Section VI). 
For comparison purposes, these relative rate rankings were 
compared with actual rate data obtained by observing diol 
formation by 1H NMR (vide infra, Section IX). Since those 
empirical data were normalized to the rate of the catalyst 
derived from salen 3b, the predicted relative rates were simi 
larly normalized. A comparison of the predicted and observed 
rates is presented in FIG. 6. 
Sele2 (E) (f, -vii.) A. éle 
v 1 + 
Sele2 B 
Sele1 V2 - V1 
Sele2 (v2 - v22) 
-- - - - - (E)-4-v2. Self E2 El 
Sele2 (E ) (v2. - v£2) 
Sele2 (i. ) v: - va, 
Sele2 (vil - via) 
-- - - - - - - (E) v.-vi. Self E2 El 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
wherein: 
A and B are two chiral catalysts, 
Sel, or Sel. V, (R:S) of the reporting enzyme for the 
diol substrate, and 
V represents the observed rate with catalyst A or B and 
enzyme E1 or E2. 
VIII. Independent Measures of Enantioselectivity 
A. Standard Jacobsen Conditions 
Salens in the fully synthetic, 42 member focused library 
that led to catalysts with appreciable activity, as indicated by 
double cuvette-ISES, were also evaluated outside of the 
cuvette, under conditions more typically employed in HKR 
reactions. Specifically, these Co(III)-salen catalysts were 
evaluated in the HKR of (+)-propylene oxide, under neat 
conditions, similar to those described by Jacobsen and 
coworkers. Reactions were arbitrarily stopped after 3 hours, 
to obtain the enantiopurity of the 1,2-propanediol product at 
relatively early reaction times, for comparison with ISES 
predictions. 
A typical procedure follows: To the Co(III)-salen catalyst 
derived from 7e (5.4 mg, 5.4 umol, 0.25 mol %) and (+)- 
propylene oxide (125 mg, 2.15 mmol) at 0°C., was added 
water (21 ul, 1.18 mmol, 0.55 equiv.). The reaction mixture 
was securely capped, and allowed to warm to room tempera 
ture and stirred, most commonly for a total of 3 hours. Percent 
conversion at 3 hours was evaluated by 1H NMR of an aliquot 
(cooled to 0°C. for the transfer), in CDC1. In most of these 
cases, the conversion was low enough after 3 hours, that the 
unreacted epoxide (bp 32°C.) was of relatively low ee, and 
was therefore removed by evaporation under aspirator 
vacuum. When the conversion was less than 5% by NMR 
after 3 hours, reactions were continued for longer times. 
Upon termination of the reaction, the diol product was 
isolated by Kugelrohr distillation (~120° C.-oven temp; 0.1 
torr). To determine ee, the isolated diol was derivatized using 
p-bromobenzoyl imidazole (2.2 equiv.) in THF in the pres 
ence of NaH (4 equiv.) at room temperature for 5 min. The 
bis(p-bromobenzoate) esters obtained following sequential 
washes with 1 NHCl and saturated sodium bicarbonate, were 
of sufficient purity to be used directly for chiral HPLC analy 
sis (Chiralcel OD, 99% hexenefi-PrCH). 

US 7,767,388 B2 
37 
-continued 
7a. 
M = Co(III), X = OAc 
(+) / \ 
0.55 equiv. H2O 
Solvent: i-PrCH/hexane (1:99); Flow Rate = 1 mL/min 
Retention Time: 14.1 (R) and 16.1 (S) 
Integration: 376.6:135.6 (47% ee) 
THF, rt 
OH NaH (4 equiv.) 
luo O Me R 
/NN N \-l 
Br 
(2.5 equiv.) 
Br 
Br 
O O 
luo Me R 
O 
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-continued 
M = Co(III), X = 3.5-Dinitrobenzoate 
(+) A 0.55 equiv. H2O 
Solvent: i-ProH/hexane (1:99); Flow Rate = 1 mL/min 
Retention Time: 14.5 (R) and 16.6 (S) 
Integration: 135.1:29.2 (64% ee) 
OH 
luoi Me1 R 
40 
THF, rt 
NaH (4 equiv.) 
O 
(2.5 equiv.) 
Br 
Br 
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-continued 
(+) H M = Co(III), X = 3.5-Dinitrobenzoate OH 
0.55 equiv. H2O 1N1 
Solvent: i-PrCH/hexane (1:99); Flow Rate = 1 mL/min 
Retention Time: 14.5 (R) and 16.4 (S) 
Integration: 10.1:135.3 (86% ee) 
OH 
42 
THF, rt 
NaH (4 equiv.) 
Br 
(2.5 equiv.) 
Br 
Br 
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The concentration of 1,2-propanediol in the aqueous layer 
TABLE S4-continued was estimated under typical ISES conditions using 1H NMR 
HKR Under Standard Jacobsen Conditions with Co(III)-Salen Catalyst Hits spectroscopy. The bilayer was prepared as usual for double 
cuvette-ISES (Section V), but for the substitution of DO for Loading 
Salen (mol%) NMR conv. (time) 9% Yield (time) 9% ee (HPLC) HO in the buffer, and the elimination of the dehydrogenase 
2g 0.25 n.d. 1 (3h), 4 (20 h) -71 (a)3 h, enzymes. After 15 min, the aqueous layer (300 uL of 500 uL 
–65(a)20 h (R) 
10 total) was withdrawn and mixed with a fresh solution of 
n.d. = not determined; 
*Indicates that the Co(III)-3,5-dinitrobenzoate catalyst was used. All other entries are for imidazole of known concentration (also 300 uL in D2O), as 
Co(III)-salen-acetate catalysts, 
an internal concentration standard. Accumulation of the 1H 
B. Catalyst Performance in the ISES Cuvette NMR spectrum, followed by integration and quantitation, 
For several catalysts, control experiments were run to 15 
assess whether running the HKR under biphasic conditions provided an experimental measure of total diol in the aque 
influences the enantioselectivity of these Co(III)-salen HKR ous reporting layer at t=15 minutes for the catalyst under 
catalysts. In Such cases, parallel duplicate double-cuvette 
runs were chosen (i.e. two HLADH cuvettes and two TBADH investigation. The observed diol concentrations for ten cata 
cuvettes for a single catalyst). Following the ISES runs, the 20 lysts examined in this way are collected in Table S6, below. 
contents of all four reporting cuvettes were merged. Unre 
acted epoxide was rapidly removed under Ar stream. Follow 
ing dilution with CHCl (~50 mL), sodium sulfate was added derived from salen3b (arbitrarily assigned a rate of 1.0). 
These have been normalized to the value for the catalyst 
TABLE S6 
Co(III)-salen-Mediated HKR: I total 1.2-Propanediol by NMR (aqueous ISES layer 
Salen 
1a. 2a 2b 1d 3b 4b 7e Sa Sb Sd 
diol 19 27.5 22 91 96 98 37 52.5 75.5 54 
(mM) (a) 15 min 
Norm. O.2O O.29 O.23 O.9S 1.0 1.02 0.39 O.S.S. O.79 O.S6 
to adsorb remaining water. The resulting organic Solution was The following examples illustrate the invention with 
filtered and the filter cake washed with CHCl (2x20 mL). respect to an in situ enzymatic screening (ISES) method to 
Following evaporation of the solvent, the crude diols were predict the enantioselectivity of chiral catalysts for the hydro 
40 lytic kinetic resolution (HKR) of (+) hexene oxide. Above, it 
was shown that the method of the invention may be employed 
to predict the enantioselectivity and relative rate of a catalyst 
library for HKR of (+)-propylene oxide using horse liver 
derivatized directly with p-bromobenzoyl imidazole to yield 
the 1,2-propanediol bis(pbromobenzoate) esters, which were 
then purified by silica gel chromatography to estimate diol 
yields. Enantiomeric excesses were determined using chiral alcohol dehydrogenase (HLADH) and Thermoalaerobium 
HPLC, as before. As can be seen from Table S5, there is no as broki alcohol dehydrogenase (TBADH). This example 
appreciable erosion of ee seen in running these HKR experi- demonstrates that an HKR substrate with a considerably 
ments under biphasic conditions. Indeed, the ee's seen from larger R grOup, hexene oxide, can also be screened by ISES 
diol isolated directly out of the cuvette generally appear using a different enzyme couple. Specifically, Lactobacillus 
slightly higher than those obtained under Jacobsen condi- Refir alcohol dehydrogenase (LKADH) shows a high (S)- 
tions, probably reflecting the shorter reaction times 50 selectivity for the oxidation of 1.2-hexenediol and HLADH 
shows a modest (S)-selectivity. 
This example demonstrates greater breadth of the tech 
TABLES5 nique, in terms of Substrate structure. Indeed, taken together, 
the propylene oxide and hexene oxide cases, show that a 
55 catalyst may be screened in a "cassette fashion” across more 
than one substrate, at once, in parallel, to give information 
employed in the ISES experiment. 
Biphasic vs. Jacobsen Conditions 
Co(III)-salen % eeneasured 90 eeneasured 90 eeeredicted about Substrate selectivity, as well as, enantioselectivity. 
(indexed by % Yield biphasic neat Jacobsen double cuvet- This example also shows that good ee predictions can be 
Salen) (isolated) conds. conditions ISES made when using two reporting enzymes with the same enan 
60 tiomeric preference, but with a significantly different magni 
1a. 1 87 72 56 tude of enantioselectivity. 
4a 1.6 82 76 77 In the experiment, each Co(III)-salen catalyst was mixed 
4 with (t)-hexene oxide and dichloromethane and placed in a 
e lower organic layer in each of two parallel cuvettes. Aqueous 
*denotes that the Co(III)-salen-3,5-dinitrobenzoate catalyst was used in this case. All other 65 reporting layers, containing LKADHANADP+ (cuvette 1) 
entries refer to runs with Co(IID salen-acetate catalysts, HLADHANAD+ (cuvette 2). were then added (Scheme 1). 
The hexenediol product diffuses from the (lower) organic 
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layer into the (upper) aqueous layer, where the HLADH and 
LKADH enzymes act as sensors, oxidizing the product, and 
producing the NAD(P)H signal. The increase of absorbance 
at 340 nm is monitored in parallel by a UV-vis spectropho 
tometer. Alternatively, the NAD(P)H fluorescence may be 
monitored (emission wavelength is typically set at a fixed 
value in the 460-470 nm), either in a cuvette or in a plate 
format. 
5 
48 
chloride and 2M 2-propanol in H.O. Enzyme units were 
calculated by measuring the rate of formation of NADH at 
340 nm for both dehydrogenases (vide infra). In each case, 
one S.I. unit is taken as the amount of enzyme catalyzing the 
formation of one umol of NAD(P)H per minute. 
Standardization of HLADH: The assay cuvette contained 
the following components: 7.2 mM (33 uL) of B-NAD", 2 ul 
S-selective sensor 
O 
(+) / \ 
HO 
Chiral Salen Catalyst 
Cuvette II 
NAD 
Aqueous layer 
Organic layer 
S-selective sensor 
O 
(+) / \ 
HO 
Chiral Salen Catalyst 
Aqueous layer 
Organic layer 
60 
Standardization of Reporting Enzymes (or 20 uL of a 1:10 dilution) of HLADH stock solution, 865 
The following stock Solutions were made for enzyme stan- uL of 50 mM sodium pyrophosphate buffer, pH 8.8, and 200 
dardization: 220 mM B-NAD", 220 mMBT-NADP", alcohol mM (100LL) of 2-propanol. The reaction was initiated by the 
dehydrogenases from horse liver (HLADH) (0.01-0.02 U/uL) is addition of 2-propanol, which typically gave a rate of 
and Lactobacillus kefir (LKADH) (0.05-0.07 U/uL) in 25 0.12+0.01 abs/min at 25°C., 340 nm. This was indicative of 
mM sodium phosphate buffer, pH 7.0, 150 mM magnesium 0.010 U of HLADH per uL of the stock solution. 
  
US 7,767,388 B2 
49 
Standardization of LKADH: The assay cuvette contained 
the following components: 2.2 mM (10 uL) f-NADP, 1.5 
mM (10 uL)MgCl2, 2 ul, (or 20 uL of 1:10 dilution) of 
LKADH stock solution, 878 uL of 50 mM sodium pyrophos 
phate buffer, pH 8.8, and 200 mM (100 uL) of 2-propanol. 
The reaction was initiated by the addition of 2-propanol, 
which typically gave a rate of 0.110+0.001 abs/min at 25°C., 
340 nm. This was indicative of 0.009 U of LKADH peruL of 
the stock Solution. 
Double Cuvette ISES Procedure for HKR of Hexene Oxide 
A general procedure for the double cuvette ISES to esti 
mate the enantiomeric excess of the 1.2-hexenediol product 
from the hydrolytic kinetic resolution (HKR) of racemic hex 
ene oxide is described below. Quartz cuvettes with a 1 cm 
light path and with a nominal 1 mL volume were used. For 
every catalyst, a two cuvette Screen was performed, with 
cuvette A containing HLADH, and cuvette B containing 
LKADH. As indicated above, both enzymes are (S)-selective, 
but differ in degree of selectivity. 
Organic Layer: Both cuvettes A and B had the following 
composition: 140 uL of (+)-hexene oxide (116 mg, 1.16 
mmols) 160 uL of CHCl (Amylene stabilized, purchased) 
and 2.0 mol % Co(III)-salen-acetate catalyst. The total 
organic layer Volume was maintained as 300 uL in all catalyst 
SCCS. 
Aqueous Layer in Cuvette A: 5.0LL (0.05 U with 2-pro 
panol) of HLADH stock solution, (0.01 U/L), 16.5 uL (7.2 
mM) of B-NAD" stock and 478.5 uL of 50 mM sodium 
pyrophosphate buffer, pH 8.8. 
Aqueous Layer in Cuvette B: 16.7 uL (0.15 U with 2-pro 
panol) of LKADH stock (0.009 U/uL), 5 uL (2.2 mM) of |-NADP" stock, 5 uL (1.5 mM) of MgCl, and 473.5 uL of 50 
mM sodium pyrophosphate buffer, pH 8.8. 
The total Volume of the aqueous layer was maintained as 
500 uL in both cuvettes in all ISES experiments. For each 
cuvette, 23 micromol of catalyst was dissolved in 160 uL of 
water saturated CHCl in a 1.5 ml microcentrifuge tube. This 
catalyst solution was kept at rt for 20-30 min. After that the 
catalyst Solution was stored in an ice bath along with (E)- 
hexene oxide separately. Every catalyst screen was done in 
duplicate (i.e. two runs of cuvette A and two of cuvette B per 
screen). Then the aqueous layers were prepared first in 1.5 mL 
microcentrifuge tubes at 25°C. and drawn into 1 mL dispos 
able syringes fitted with 19 gauge stainless steel needles. This 
was done about 2 min before layering. 
Following this, the organic layers were prepared in 1.5 mL. 
microcentrifuge tubes by briefly mixing the catalyst Solution 
with 140LL (1.16 mmols) of (+)-hexene oxide in an ice bath. 
Immediately, they were loaded in 1 ml quartz cuvettes, using 
1 mL disposable syringes. The aqueous layer was then added 
carefully along the walls of the cuvette. A reversed loading 
method (aqueous layer was loaded first inside the cuvette, 
then the organic layer was loaded on the bottom by injecting 
it slowly at the bottom of the cuvette through the aqueous 
layer.) was adopted for the catalysts derived from 1-hy 
drdoxy-2-naphthaldehyde to improve solubility. This was 
followed by the parallel observation of continuous NAD(P)H 
formation at 340 nm in both reporting cuvettes, using a 
UV/vis spectrophotometer with six cell positioner at 25°C. 
The enantiomeric ratio was predicted using the rate of 
change of absorption (i.e. AAbs/time) from the 0-10 min 
window for all catalysts. No prediction was attempted for 
very slow catalysts (i.e., s 15 mAbs/min in 0-10 min time 
window for HLADH cuvettes). 
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Hydrolytic Kinetic Resolution of (+)-Hexene Oxide 
Co(III)-salen (acetate) catalysts were evaluated for HKR of 
(t)-hexene oxide, under neat conditions, similar to those 
described by Jacobsen and co-workers (Schaus, S. E.; 
Brandes, B. D.; Larrow, J. F.; Tokunaga, M.: Hansen, K. B.: 
Gould, A. E.; Furrow, M. E.; Jacobsen, E. N. J. Am. Chem. 
Soc. 2002, 124, 1307-1315). Reactions were stopped after 0.5 
h, to obtain the enantiopurity of the 1.2-hexenediol produced 
at relatively early reaction times, for comparison with bipha 
sic ISES predictions. 
A typical procedure follows: To the Co(III)-salen catalyst 
derived from 1e (16.6 mg, 23.2 umol. 2.0 mol %) at rt was 
added (+)-hexene oxide (116 mg, 1.16 mmols). The mixture 
was cooled to 0°C. Then water (11.4 uL, 0.64 mmols, 0.55 
equiv.) was added and the flask was capped tightly and stirred 
25°C. for 30 min. The progress of the reaction was estimated 
by H NMR, the reaction mixture was cooled to 0°C., an 
aliquot was then withdrawn and dissolved in CDC1 at 0°C. 
bath. After distilling over the unreacted epoxide, the diol 
product was collected, and then itself distilled again by 
Kugelrohr. When the reaction conversion was more than 50% 
in 30 min, 15 min reaction time was used (for catalyst 1e) to 
get the product diol. 
To determine ee, the isolated diol was derivatized using 
p-bromobenzoyl imidazole (2.2 equiv.) in THF in the pres 
ence of NaH (4 equiv.) at rt for 5 min. The bis(p-bromoben 
Zoate) obtained following sequential washes with 1 NHCl 
and bicarbonate (sat daqueous), was of Sufficient purity to be 
used directly for chiral HPLC analysis Chiralcel OD, (99:1 
hexanes/2-PrOH: 1 mL/min). 
A number of “Co(III)-salen” catalysts (FIGS. 7-7C) were 
subjected to "cassette screening” for the HKR of both (+)- 
propylene oxide and (+)-hexene oxide, using UV/vis spec 
troscopy. A comparison between the predicted and the mea 
suredee's for the HKR of (+)-propylene oxide is presented in 
FIG. 5. Above a 50% ee threshold, in either direction, ISES 
found 5 of 5 hits (within a 21% ee margin). For the HKR of 
(t)-hexene oxide, a comparison between the predicted and 
the measuredee's is presented in FIG. 6. Above a 50% thresh 
old in either direction, ISES finds 7 of 7 hits within a 24% ee 
margin. Note that this is particularly good since the biphasic 
ISES conditions are being used to predict ee's measured 
under Jacobsen's HKR conditions (“neat' epoxide, contain 
ing 0.55 equivalents of water). 
While the invention has been described with respect to 
specific examples including presently preferred modes of 
carrying out the invention, those skilled in the art will appre 
ciate that there are numerous variations and permutations of 
the above described systems and techniques that fall within 
the spirit and scope of the invention as set forth in the 
appended claims. 
We claim: 
1. A method for monitoring the stereoselectivity of at least 
one organic chemical reaction and the relative rate of at least 
one organic chemical reaction, wherein the reaction produces 
a product that can exist as at least two stereoisomers, the 
process comprising: 
providing a first reaction Zone containing (1) an organic 
phase comprising the reaction mixture for producing 
said product and (2) an aqueous phase adjacent to, but 
Substantially immiscible with said organic phase, said 
aqueous phase containing at least one first sensing agent 
that preferentially acts on a first stereoisomer in said 
product to produce a monitorable change, said product 
being diffusible into said aqueous phase (2); 
providing a second reaction Zone containing (A) an organic 
phase also comprising the reaction mixture for produc 
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ing said product and (B) an aqueous phase adjacent to, 
but Substantially immiscible with said organic phase, 
said aqueous phase containing at least one second sens 
ing agent that is different from said first sensing agent 
and 
i preferentially acts on the first stereoisomer in the 
product, but with a different stereoselectivity for the 
stereoisomers formed in the product than the first 
sensing agent to produce a monitorable change or 
ii acts at equal rates on both formed Stereoisomers of 
the product to produce a monitorable change or 
iii preferentially acts on a second stereoisomer in the 
product to produce a monitorable change, 
said product being diffusible into said aqueous phase 
(B), 
conducting said reactions in said organic phases (1) and 
(A) to produce said product, 
allowing said product to diffuse into said aqueous phases 
(2) and (B) and react with said first and second sensing 
agents, 
monitoring the changes caused by said reactions with said 
first and second sensing agents and 
correlating said changes to determine the relative rate and 
stereoselectivity of said organic chemical reaction in 
said organic phases (1) and (A). 
2. The method of claim 1 wherein said first and second 
sensing agents are enzymes. 
3. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are spectro 
Scopic. 
4. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are visible to 
the human eye, and are recorded photographically and quan 
titated by analyzing image pixel density. 
5. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are deter 
mined by measurement of absorbance in the UV or visible 
region of the spectrum. 
6. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are deter 
mined by measurement of fluorescence. 
7. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are visible to 
the human eye and are measured visibly or photographically 
in a microtitre plate format. 
8. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are visible to 
the human eye and are measured visibly or photographically 
in a reaction vessel or a multimicrocell. 
9. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are mea 
sured by UV/visible spectroscopy in cuvettes or a multimi 
crocell, using a spectrophotometer equipped with an auto 
mated cell positioner or with multimicrocell-reading 
capability. 
10. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are mea 
sured by UV/visible spectroscopy in a microtitre plate format. 
11. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are deter 
mined by measurement of fluorescence in the visible region 
using the human eye or photography. 
12. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are deter 
mined by measurement of fluorescence in the UV or visible 
region using a fluorescence spectrophotometer. 
10 
15 
25 
30 
35 
40 
45 
50 
55 
60 
65 
52 
13. The method of claim 1 wherein said monitorable 
changes produced in aqueous phases (2) and (B) are deter 
mined by measurement of fluorescence in the UV or visible 
region using a plate-reading fluorescence spectrophotometer. 
14. The method of claim 1 wherein said reaction mixture 
contains at least one catalyst for said reaction. 
15. The method of claim 14 wherein said at least one 
catalyst is a Co(III)-salen complex. 
16. The method of claim 15 wherein said Co(III)-salen 
complex is selected from the group consisting of 
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17. The method of claim 1 wherein said product is an 
-continued alcohol and said sensing agents in aqueous phases (2) and (B) 
O O-Me - 0 Me lo are alcohol dehydrogenase or oxidase enzymes that oxidize 
Yo said product. 
Me 5 18. The method of claim 17 wherein said alcohol product is 
N N a diol. 
N^ 19. The method of claim 18 wherein said diol is a 1,2-diol. 
/No 20. The method of claim 19 wherein said diol is propane 
C 10 1 2-diol or hexene-1,2-diol. 
21. The method of claim 17 wherein the sensing agents are 
Horse Liver Alcohol Dehydrogenase (HLADH) and Ther 
O-Me moanaerobium brocki Dehydrogenase (TBADH). 
Me O lo 15 22. The method of claim 17 wherein the sensing agents are 
Yo Horse Liver Alcohol Dehydrogenase (HLADH) and Lacto 
Me bacillus kefir Dehydrogenase (LKADH). 
SN NS 23. The method of claim 17 wherein said alcohol is a 
N/ 20 halohydrin, a f-azido alcohol, a f-cyanalcohol, a f-alkoxy 
/ N alcohol, a 3-aryloxy alcohol, a B-thioalkyl alcohol, or a 
I O AcO I; B-amino alcohol. 
24. The method of claim 17 wherein said alcohol is the 
I I O-M 25 product of an aldol-type condensation, wherein a carbon acid 
Me O w e having a proton alpha to one or more electron-withdrawing 
?o groups is condensed with an aldehyde and is deprotonated in the course of the condensation. 
SN NS 25. The method of claim 17 wherein said alcohol is the 
N/ 30 product of a Morita-Baylis-Hillman reaction. 
/ N 26. The method of claim 17 wherein said alcohol is the 
product of a carbonyl reduction reaction. 
27. The method of claim 17 wherein said alcohol is a 
BO OBn; and 35 cyanohydrin. 
Me O p -Me 28. The method of claim 1 wherein said product is an amine 
Yo and said sensing agents in aqueous phases (2) and (B) are 
amine dehydrogenase or amine oxidase enzymes that oxidize 
N N 40 said product. 
N/ 29. The method of claim 1 wherein said product is an 
/ N aldehyde or hemiacetal and said sensing agents in aqueous 
O AcO phases (2) and (B) are aldehyde or alcohol dehydrogenase 
enzymes that oxidize said product. 
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